Quest PharmaTech Inc.
QPTFF
$0.0133
-$0.0017-11.33%
OTC PK
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 26.48% | 6.90% | 26.74% | 46.85% | -32.75% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -25.26% | -32.39% | 34.85% | 53.31% | 43.85% |
| Operating Income | 25.26% | 32.39% | -34.85% | -53.31% | -43.85% |
| Income Before Tax | 122.64% | 121.34% | 119.81% | 120.65% | 24.04% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 122.64% | 121.34% | 119.81% | 120.65% | 24.04% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 122.64% | 121.34% | 119.81% | 120.65% | 24.04% |
| EBIT | 25.26% | 32.39% | -34.85% | -53.31% | -43.85% |
| EBITDA | 25.24% | 32.31% | -35.16% | -55.55% | -45.97% |
| EPS Basic | 122.39% | 121.09% | 119.56% | 120.41% | 23.63% |
| Normalized Basic EPS | 17.39% | 11.86% | 8.33% | 53.00% | 96.98% |
| EPS Diluted | 122.39% | 121.09% | 119.54% | 120.39% | 23.69% |
| Normalized Diluted EPS | 17.39% | 11.86% | 8.33% | 53.00% | 96.98% |
| Average Basic Shares Outstanding | 0.27% | 0.29% | 0.32% | 0.43% | 0.03% |
| Average Diluted Shares Outstanding | 0.27% | 0.29% | 0.32% | 0.43% | 0.03% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |